Brand name authorized in: Austria Poland
The drug ADAMON contains one active pharmaceutical ingredient (API):
Tramadol, a cyclohexanol derivative, is a centrally acting opioid analgesic. It is a non-selective pure agonist at μ, δ and κ opioid receptors with a higher affinity for the μ receptor. Other mechanisms which contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: